Wound Care Market in Ghana to Expand Gradually by 2035

 

The Ghana active wound care market is poised for steady growth, projected to expand from a valuation of USD 663.8 thousand in 2024 to USD 863.0 thousand by 2035, at a compound annual growth rate (CAGR) of 2.2% between 2025 and 2035. The market is witnessing transformation driven by the rise in chronic wound incidences, a shift toward advanced wound management technologies, and significant developments in Ghana’s healthcare infrastructure.

 

Market Overview: Active wound care involves advanced therapies and products that promote faster and more effective wound healing compared to traditional methods. In Ghana, the growing burden of chronic wounds commonly associated with diabetes, vascular disorders, and hypertension has underscored the demand for innovative wound care solutions, including biomaterials, skin-substitutes, and growth factors.

 

Market Drivers & Trends

One of the primary drivers of the Ghana active wound care market is the increasing prevalence of chronic wounds, with studies reporting diabetic foot ulcer rates in Ghana between 3.8% and 11%, and Ghana accounting for 17% of global Buruli ulcer cases. These conditions, often stemming from diabetes and other non-communicable diseases, are becoming more common as the population ages and urban lifestyles intensify.

Additionally, Ghana's expanding healthcare infrastructure is a significant enabler. Newly constructed hospitals, government health programs like Mahama Cares, and public-private partnerships are improving access to advanced wound care technologies.

Healthcare professionals in Ghana are increasingly participating in training programs and workshops to stay updated on advanced wound care methods. Clinics and hospitals are investing in seminars to improve knowledge on biomaterials, telemedicine platforms, and patient-centric wound care strategies.

 

Latest Market Trends

Recent trends shaping the Ghanaian wound care landscape include:

• Wider adoption of skin-substitutes and bioactive materials for difficult-to-heal wounds.
• Integration of digital health platforms, allowing real-time monitoring and follow-up of chronic wound cases via telemedicine.
• Enhanced focus on education for healthcare staff, ensuring competency in deploying high-end wound care technologies.
• Increased funding from international donors and NGOs to improve wound care access in underserved areas.

 

Key Players and Industry Leaders

Key industry participants are heavily investing in the Ghana market to leverage untapped opportunities. Leading companies include:

• Smith+Nephew
• Johnson & Johnson Services, Inc.
• Solventum
• Organogenesis Inc.
• Convatec
• Aspire Medical Innovation
• Factor Medical, Inc.

These firms are introducing next-generation wound care solutions, collaborating with local institutions, and conducting awareness campaigns and training initiatives for clinicians.

 

Recent Developments

The global wound care industry has made significant strides in innovation, influencing Ghana’s market. Key global developments include:

• April 2025: Abeona Therapeutics secured FDA approval for ZEVASKYN, the first gene-modified cellular sheet therapy for recessive dystrophic epidermolysis bullosa.
• February 2025: The U.S. FDA granted breakthrough therapy designation to SkinTE for diabetic foot ulcers, with significantly improved wound closure outcomes in clinical trials.
• August 2024: Vericel Corporation received FDA approval for NexoBrid use in pediatric burn wound management.

These innovations are expected to be gradually introduced to emerging markets like Ghana, further boosting treatment efficacy.

 

Market Opportunities and Challenges

Opportunities:

• Growing demand for advanced wound therapies, particularly in urban hospitals and private clinics.
• Expansion of mobile health (mHealth) and telemedicine services to bridge rural healthcare access gaps.
• International donor support and government funding to subsidize costs of advanced wound care.

Challenges:

• High costs of advanced products may limit adoption, particularly in public hospitals.
• Limited awareness in rural communities about wound care best practices and available treatments.
• Supply chain constraints and regulatory hurdles for introducing innovative medical devices.

 

Access an overview of significant conclusions from our Report in this sample

 

Future Outlook

The Ghana active wound care market is projected to grow steadily through 2035, supported by:

• Continued increase in chronic wound prevalence due to aging population and lifestyle diseases.
• Expanded government health initiatives and infrastructure investments.
• Rising healthcare education among clinicians and broader acceptance of modern wound care techniques.

With growing awareness and more efficient healthcare delivery mechanisms, Ghana is expected to become a key market for biomaterials, skin-substitutes, and growth factor therapies over the next decade.

 

Market Segmentation

By Product Type:

• Biomaterials (Leading segment)
• Skin-substitutes
• Biological skin-substitute
• Synthetic skin-substitute
• Growth Factors

By Application:

• Chronic Wounds (Dominant application)
• Acute Wounds

By End User:

• Hospitals
• Clinics
• Others

 

Regional Insights

Though this market is Ghana-specific, regional disparities exist within the country. Urban areas such as Accra, Kumasi, and Takoradi are leading in advanced wound care adoption due to the presence of well-equipped hospitals and higher awareness levels. In contrast, rural and peri-urban areas still face access challenges, which present opportunities for mobile wound care services and NGO-led health outreach.

Recent infrastructure projects, such as the 40-bed hospital in Accra built by Czech company Vamed Health Projects, reflect Ghana’s commitment to bridging regional health gaps and ensuring equitable access to modern treatments.

 

Why Buy This Report?

This detailed research study offers a comprehensive overview of Ghana’s active wound care market, enabling stakeholders to:

• Identify emerging market trends and key growth drivers.
• Understand competitive dynamics, including profiles of major players.
• Evaluate market segmentation and product opportunities by type and application.
• Analyze challenges and investment risks, particularly in infrastructure and regulation.
• Plan effective market entry and expansion strategies in the Ghanaian healthcare sector.

 

Explore Latest Research Reports by Transparency Market Research:

Vascular Snare Market: https://www.transparencymarketresearch.com/vascular-snare-market.html

Raloxifene Hydrochloride Market: https://www.transparencymarketresearch.com/raloxifene-hydrochloride-market.html

Dysphagia Management Market: https://www.transparencymarketresearch.com/dysphagia-management-market-report.html

Nucleic Acid Therapeutics Market: https://www.transparencymarketresearch.com/nucleic-acid-therapeutics-market.html

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com 
Email: sales@transparencymarketresearch.com